510(k) K170267

BGM009 Plus Blood Glucose Monitoring System by Apex BioTechnology Corp. — Product Code NBW

K170267 is an FDA 510(k) premarket notification submitted by Apex BioTechnology Corp. for the device "BGM009 Plus Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on March 9, 2017. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. Apex BioTechnology Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 9, 2017
Date Received
January 27, 2017
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Blood Glucose, Over The Counter
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type